Back to Search
Start Over
Ethnicity/race, use of pharmacotherapy, scope of physician-ordered cholesterol screening, and provision of diet/nutrition or exercise counseling during US office-based visits by patients with hyperlipidemia.
- Source :
-
American journal of cardiovascular drugs : drugs, devices, and other interventions [Am J Cardiovasc Drugs] 2010; Vol. 10 (2), pp. 105-8. - Publication Year :
- 2010
-
Abstract
- Background: Elevation of serum cholesterol, or hyperlipidemia, is recognized as one of the major modifiable risk factors in the development of atherosclerosis and cardiovascular disease. On a US population basis, there has been a downward trend in total- and LDL-cholesterol levels, and an increase in cholesterol screening. Nevertheless, previous research suggests that there remain racial/ethnic disparities in the access to and quality of care for hyperlipidemia.<br />Objective: The aim of this study was to examine the extent of racial/ethnic disparities in the provision of pharmacotherapy, cholesterol screening and diet/nutrition or exercise counseling during US office-based physician-patient encounters (visits) by patients with hyperlipidemia.<br />Methods: We examined data from the 2005 US National Ambulatory Medical Care Survey for office-based visits for hyperlipidemia for patients aged > or =20 years in terms of prescribing for hyperlipidemia, and the ordering/provision of cholesterol testing, diet/nutrition counseling, and exercise counseling.<br />Results: Use of pharmacotherapy for hyperlipidemia varied by ethnicity/race (chi2, p < 0.05). Physician-ordered/provided cholesterol screening occurred in 44.2% of all office-based visits; 46.5% for Whites, 35.4% for Blacks, and 30.3% for Hispanics (chi2, p < 0.05). Diet/nutrition counseling was ordered/provided in 39.7% of office-based visits; 40.4% for Whites, 32.6% for Blacks, and 39.0% for Hispanics (chi2, p < 0.05). Exercise counseling was ordered/provided in 32.1% of office-based visits; 32.7% for Whites, 27.2% for Blacks, and 30.6% for Hispanics (chi2, p < 0.05).<br />Conclusions: These findings reveal a disparity in use of pharmacotherapy for hyperlipidemia, physician-ordered/provided cholesterol screening, diet/nutrition counseling, and exercise counseling by ethnicity/race. Further research is required to discern, in greater detail, reasons for the observed differences reported, and to ensure equitable access to established standards of care.
- Subjects :
- Adult
Black or African American statistics & numerical data
Aged
Cholesterol blood
Directive Counseling standards
Exercise Therapy
Female
Health Care Surveys
Health Services Accessibility statistics & numerical data
Hispanic or Latino statistics & numerical data
Humans
Male
Mass Screening methods
Middle Aged
Office Visits statistics & numerical data
Practice Patterns, Physicians' standards
United States epidemiology
White People statistics & numerical data
Young Adult
Directive Counseling statistics & numerical data
Healthcare Disparities statistics & numerical data
Hyperlipidemias therapy
Practice Patterns, Physicians' statistics & numerical data
Subjects
Details
- Language :
- English
- ISSN :
- 1175-3277
- Volume :
- 10
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- American journal of cardiovascular drugs : drugs, devices, and other interventions
- Publication Type :
- Academic Journal
- Accession number :
- 20334447
- Full Text :
- https://doi.org/10.2165/11532820-000000000-00000